aluates Reports

$ 0.0

Automative

Global Argininemia Drugs Market Insights, Forecast to 2030

Published Date: December 2024

Report Code: QYRE-Auto-11E9950

Global Argininemia Drugs Market Insights Forecast to 2028

BUY CHAPTERS

Global Argininemia Drugs Market Insights, Forecast to 2030

Code: QYRE-Auto-11E9950

Report

December 2024

Pages:71

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Helsinn Healthcare

Novartis Pharmaceuticals

Horizon Pharma

Medicis Pharmaceutical

Argininemia Drugs Market Size

The global Argininemia Drugs market is projected to grow from US$ 107 million in 2024 to US$ 137 million by 2030, at a Compound Annual Growth Rate (CAGR) of 4.2% during the forecast period.

Argininemia Drugs Market

Argininemia, also called arginase deficiency, is an autosomal recessive urea cycle disorder where adeficiency of the enzyme arginase causes a buildup of arginine and ammonia in the blood.

The Arginase deficiency drugs market is driven by the growing awareness and diagnosis of this rare genetic disorder. As understanding of the disease improves, more patients are being identified and seeking treatment options. The development of targeted therapies to address the underlying metabolic abnormalities associated with Arginase deficiency has also contributed to market growth. Additionally, government initiatives and orphan drug designations have facilitated research and development in this area. However, the market faces challenges like limited patient populations, high treatment costs, and the need for specialized medical expertise for diagnosis and management. Overcoming these challenges through increased awareness, early diagnosis, and affordable access to therapies will be essential for the sustained growth of the Arginase deficiency drugs market.

Report Covers:

This report presents an overview of global market for Argininemia Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Argininemia Drugs, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Argininemia Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Argininemia Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Argininemia Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Argininemia Drugs sales, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Argininemia Drugs Market Report

Report Metric	Details
Report Name	Argininemia Drugs Market
Accounted market size in 2024	US$ 107 in million
Forecasted market size in 2030	US$ 137 million
CAGR	4.2
Base Year	2024
Forecasted years	2025 - 2030
Segment by Type	Oral Injection
Segment by Application	Hospital Drugs Stores Other
Segment by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Horizon Pharma, Medicis Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Argininemia Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Argininemia Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Argininemia Drugs sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

FAQ for this report

How fast is Argininemia Drugs Market growing?

Ans: The Argininemia Drugs Market witnessing a CAGR of 4.2 during the forecast period 2025-2030.

What is the Argininemia Drugs Market size in 2030?

Ans: The Argininemia Drugs Market size in 2030 will be US$ 137 million.

Who are the main players in the Argininemia Drugs Market report?

Ans: The main players in the Argininemia Drugs Market are Horizon Pharma, Medicis Pharmaceutical

What are the Application segmentation covered in the Argininemia Drugs Market report?

Ans: The Applications covered in the Argininemia Drugs Market report are Hospital, Drugs Stores, Other

What are the Type segmentation covered in the Argininemia Drugs Market report?

Ans: The Types covered in the Argininemia Drugs Market report are Oral, Injection

1 Study Coverage

1.1 Argininemia Drugs Product Introduction

1.2 Market by Type

1.2.1 Global Argininemia Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Oral

1.2.3 Injection

1.3 Market by Application

1.3.1 Global Argininemia Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Hospital

1.3.3 Drugs Stores

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Argininemia Drugs Sales Estimates and Forecasts 2019-2030

2.2 Global Argininemia Drugs Revenue by Region

2.2.1 Global Argininemia Drugs Revenue by Region: 2019 VS 2023 VS 2030

2.2.2 Global Argininemia Drugs Revenue by Region (2019-2024)

2.2.3 Global Argininemia Drugs Revenue by Region (2025-2030)

2.2.4 Global Argininemia Drugs Revenue Market Share by Region (2019-2030)

2.3 Global Argininemia Drugs Sales Estimates and Forecasts 2019-2030

2.4 Global Argininemia Drugs Sales by Region

2.4.1 Global Argininemia Drugs Sales by Region: 2019 VS 2023 VS 2030

2.4.2 Global Argininemia Drugs Sales by Region (2019-2024)

2.4.3 Global Argininemia Drugs Sales by Region (2025-2030)

2.4.4 Global Argininemia Drugs Sales Market Share by Region (2019-2030)

2.5 US & Canada

2.6 Europe

2.7 China

2.8 Asia (excluding China)

2.9 Middle East, Africa and Latin America

3 Competition by Manufactures

3.1 Global Argininemia Drugs Sales by Manufacturers

3.1.1 Global Argininemia Drugs Sales by Manufacturers (2019-2024)

3.1.2 Global Argininemia Drugs Sales Market Share by Manufacturers (2019-2024)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Argininemia Drugs in 2023

3.2 Global Argininemia Drugs Revenue by Manufacturers

3.2.1 Global Argininemia Drugs Revenue by Manufacturers (2019-2024)

3.2.2 Global Argininemia Drugs Revenue Market Share by Manufacturers (2019-2024)

3.2.3 Global Top 10 and Top 5 Companies by Argininemia Drugs Revenue in 2023

3.3 Global Key Players of Argininemia Drugs, Industry Ranking, 2022 VS 2023 VS 2024

3.4 Global Argininemia Drugs Sales Price by Manufacturers

3.5 Analysis of Competitive Landscape

3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.5.2 Global Argininemia Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.6 Global Key Manufacturers of Argininemia Drugs, Manufacturing Base Distribution and Headquarters

3.7 Global Key Manufacturers of Argininemia Drugs, Product Offered and Application

3.8 Global Key Manufacturers of Argininemia Drugs, Date of Enter into This Industry

3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Argininemia Drugs Sales by Type

4.1.1 Global Argininemia Drugs Historical Sales by Type (2019-2024)

4.1.2 Global Argininemia Drugs Forecasted Sales by Type (2025-2030)

4.1.3 Global Argininemia Drugs Sales Market Share by Type (2019-2030)

4.2 Global Argininemia Drugs Revenue by Type

4.2.1 Global Argininemia Drugs Historical Revenue by Type (2019-2024)

4.2.2 Global Argininemia Drugs Forecasted Revenue by Type (2025-2030)

4.2.3 Global Argininemia Drugs Revenue Market Share by Type (2019-2030)

4.3 Global Argininemia Drugs Price by Type

4.3.1 Global Argininemia Drugs Price by Type (2019-2024)

4.3.2 Global Argininemia Drugs Price Forecast by Type (2025-2030)

5 Market Size by Application

5.1 Global Argininemia Drugs Sales by Application

5.1.1 Global Argininemia Drugs Historical Sales by Application (2019-2024)

5.1.2 Global Argininemia Drugs Forecasted Sales by Application (2025-2030)

5.1.3 Global Argininemia Drugs Sales Market Share by Application (2019-2030)

5.2 Global Argininemia Drugs Revenue by Application

5.2.1 Global Argininemia Drugs Historical Revenue by Application (2019-2024)

5.2.2 Global Argininemia Drugs Forecasted Revenue by Application (2025-2030)

5.2.3 Global Argininemia Drugs Revenue Market Share by Application (2019-2030)

5.3 Global Argininemia Drugs Price by Application

5.3.1 Global Argininemia Drugs Price by Application (2019-2024)

5.3.2 Global Argininemia Drugs Price Forecast by Application (2025-2030)

6 US & Canada

6.1 US & Canada Argininemia Drugs Market Size by Type

6.1.1 US & Canada Argininemia Drugs Sales by Type (2019-2030)

6.1.2 US & Canada Argininemia Drugs Revenue by Type (2019-2030)

6.2 US & Canada Argininemia Drugs Market Size by Application

6.2.1 US & Canada Argininemia Drugs Sales by Application (2019-2030)

6.2.2 US & Canada Argininemia Drugs Revenue by Application (2019-2030)

6.3 US & Canada Argininemia Drugs Market Size by Country

6.3.1 US & Canada Argininemia Drugs Revenue by Country: 2019 VS 2023 VS 2030

6.3.2 US & Canada Argininemia Drugs Sales by Country (2019-2030)

6.3.3 US & Canada Argininemia Drugs Revenue by Country (2019-2030)

6.3.4 US

6.3.5 Canada

7 Europe

7.1 Europe Argininemia Drugs Market Size by Type

7.1.1 Europe Argininemia Drugs Sales by Type (2019-2030)

7.1.2 Europe Argininemia Drugs Revenue by Type (2019-2030)

7.2 Europe Argininemia Drugs Market Size by Application

7.2.1 Europe Argininemia Drugs Sales by Application (2019-2030)

7.2.2 Europe Argininemia Drugs Revenue by Application (2019-2030)

7.3 Europe Argininemia Drugs Market Size by Country

7.3.1 Europe Argininemia Drugs Revenue by Country: 2019 VS 2023 VS 2030

7.3.2 Europe Argininemia Drugs Sales by Country (2019-2030)

7.3.3 Europe Argininemia Drugs Revenue by Country (2019-2030)

7.3.4 Germany

7.3.5 France

7.3.6 U.K.

7.3.7 Italy

7.3.8 Russia

8 China

8.1 China Argininemia Drugs Market Size

8.1.1 China Argininemia Drugs Sales (2019-2030)

8.1.2 China Argininemia Drugs Revenue (2019-2030)

8.2 China Argininemia Drugs Market Size by Application

8.2.1 China Argininemia Drugs Sales by Application (2019-2030)

8.2.2 China Argininemia Drugs Revenue by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Argininemia Drugs Market Size by Type

9.1.1 Asia Argininemia Drugs Sales by Type (2019-2030)

9.1.2 Asia Argininemia Drugs Revenue by Type (2019-2030)

9.2 Asia Argininemia Drugs Market Size by Application

9.2.1 Asia Argininemia Drugs Sales by Application (2019-2030)

9.2.2 Asia Argininemia Drugs Revenue by Application (2019-2030)

9.3 Asia Argininemia Drugs Sales by Region

9.3.1 Asia Argininemia Drugs Revenue by Region: 2019 VS 2023 VS 2030

9.3.2 Asia Argininemia Drugs Revenue by Region (2019-2030)

9.3.3 Asia Argininemia Drugs Sales by Region (2019-2030)

9.3.4 Japan

9.3.5 South Korea

9.3.6 China Taiwan

9.3.7 Southeast Asia

9.3.8 India

10 Middle East, Africa and Latin America

10.1 Middle East, Africa and Latin America Argininemia Drugs Market Size by Type

10.1.1 Middle East, Africa and Latin America Argininemia Drugs Sales by Type (2019-2030)

10.1.2 Middle East, Africa and Latin America Argininemia Drugs Revenue by Type (2019-2030)

10.2 Middle East, Africa and Latin America Argininemia Drugs Market Size by Application

10.2.1 Middle East, Africa and Latin America Argininemia Drugs Sales by Application (2019-2030)

10.2.2 Middle East, Africa and Latin America Argininemia Drugs Revenue by Application (2019-2030)

10.3 Middle East, Africa and Latin America Argininemia Drugs Sales by Country

10.3.1 Middle East, Africa and Latin America Argininemia Drugs Revenue by Country: 2019 VS 2023 VS 2030

10.3.2 Middle East, Africa and Latin America Argininemia Drugs Revenue by Country (2019-2030)

10.3.3 Middle East, Africa and Latin America Argininemia Drugs Sales by Country (2019-2030)

10.3.4 Brazil

10.3.5 Mexico

10.3.6 Turkey

10.3.7 Israel

10.3.8 GCC Countries

11 Company Profiles

11.1 Helsinn Healthcare

11.1.1 Helsinn Healthcare Company Information

11.1.2 Helsinn Healthcare Overview

11.1.3 Helsinn Healthcare Argininemia Drugs Sales, Price, Revenue and Gross Margin (2019-2024)

11.1.4 Helsinn Healthcare Argininemia Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 Helsinn Healthcare Recent Developments

11.2 Novartis Pharmaceuticals

11.2.1 Novartis Pharmaceuticals Company Information

11.2.2 Novartis Pharmaceuticals Overview

11.2.3 Novartis Pharmaceuticals Argininemia Drugs Sales, Price, Revenue and Gross Margin (2019-2024)

11.2.4 Novartis Pharmaceuticals Argininemia Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 Novartis Pharmaceuticals Recent Developments

11.3 Horizon Pharma

11.3.1 Horizon Pharma Company Information

11.3.2 Horizon Pharma Overview

11.3.3 Horizon Pharma Argininemia Drugs Sales, Price, Revenue and Gross Margin (2019-2024)

11.3.4 Horizon Pharma Argininemia Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 Horizon Pharma Recent Developments

11.4 Medicis Pharmaceutical

11.4.1 Medicis Pharmaceutical Company Information

11.4.2 Medicis Pharmaceutical Overview

11.4.3 Medicis Pharmaceutical Argininemia Drugs Sales, Price, Revenue and Gross Margin (2019-2024)

11.4.4 Medicis Pharmaceutical Argininemia Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 Medicis Pharmaceutical Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Argininemia Drugs Industry Chain Analysis

12.2 Argininemia Drugs Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Argininemia Drugs Production Mode & Process

12.4 Argininemia Drugs Sales and Marketing

12.4.1 Argininemia Drugs Sales Channels

12.4.2 Argininemia Drugs Distributors

12.5 Argininemia Drugs Customers

13 Market Dynamics

13.1 Argininemia Drugs Industry Trends

13.2 Argininemia Drugs Market Drivers

13.3 Argininemia Drugs Market Challenges

13.4 Argininemia Drugs Market Restraints

14 Key Findings in The Global Argininemia Drugs Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

FEATURED COMPANIES

Helsinn Healthcare

Novartis Pharmaceuticals

Horizon Pharma

Medicis Pharmaceutical

List of Tables

Table 1. Global Argininemia Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Table 2. Major Manufacturers of Oral

Table 3. Major Manufacturers of Injection

Table 4. Global Argininemia Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Table 5. Global Argininemia Drugs Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 6. Global Argininemia Drugs Revenue by Region (2019-2024) & (US$ Million)

Table 7. Global Argininemia Drugs Revenue by Region (2025-2030) & (US$ Million)

Table 8. Global Argininemia Drugs Revenue Market Share by Region (2019-2024)

Table 9. Global Argininemia Drugs Revenue Market Share by Region (2025-2030)

Table 10. Global Argininemia Drugs Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 11. Global Argininemia Drugs Sales by Region (2019-2024) & (K Unit)

Table 12. Global Argininemia Drugs Sales by Region (2025-2030) & (K Unit)

Table 13. Global Argininemia Drugs Sales Market Share by Region (2019-2024)

Table 14. Global Argininemia Drugs Sales Market Share by Region (2025-2030)

Table 15. Global Argininemia Drugs Sales by Manufacturers (2019-2024) & (K Unit)

Table 16. Global Argininemia Drugs Sales Share by Manufacturers (2019-2024)

Table 17. Global Argininemia Drugs Revenue by Manufacturers (2019-2024) & (US$ Million)

Table 18. Global Argininemia Drugs Revenue Share by Manufacturers (2019-2024)

Table 19. Global Key Players of Argininemia Drugs, Industry Ranking, 2022 VS 2023 VS 2024

Table 20. Argininemia Drugs Price by Manufacturers 2019-2024 (USD/Unit)

Table 21. Global Argininemia Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 22. Global Argininemia Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Argininemia Drugs as of 2023)

Table 23. Global Key Manufacturers of Argininemia Drugs, Manufacturing Base Distribution and Headquarters

Table 24. Global Key Manufacturers of Argininemia Drugs, Product Offered and Application

Table 25. Global Key Manufacturers of Argininemia Drugs, Date of Enter into This Industry

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. Global Argininemia Drugs Sales by Type (2019-2024) & (K Unit)

Table 28. Global Argininemia Drugs Sales by Type (2025-2030) & (K Unit)

Table 29. Global Argininemia Drugs Sales Share by Type (2019-2024)

Table 30. Global Argininemia Drugs Sales Share by Type (2025-2030)

Table 31. Global Argininemia Drugs Revenue by Type (2019-2024) & (US$ Million)

Table 32. Global Argininemia Drugs Revenue by Type (2025-2030) & (US$ Million)

Table 33. Global Argininemia Drugs Revenue Share by Type (2019-2024)

Table 34. Global Argininemia Drugs Revenue Share by Type (2025-2030)

Table 35. Argininemia Drugs Price by Type (2019-2024) & (USD/Unit)

Table 36. Global Argininemia Drugs Price Forecast by Type (2025-2030) & (USD/Unit)

Table 37. Global Argininemia Drugs Sales by Application (2019-2024) & (K Unit)

Table 38. Global Argininemia Drugs Sales by Application (2025-2030) & (K Unit)

Table 39. Global Argininemia Drugs Sales Share by Application (2019-2024)

Table 40. Global Argininemia Drugs Sales Share by Application (2025-2030)

Table 41. Global Argininemia Drugs Revenue by Application (2019-2024) & (US$ Million)

Table 42. Global Argininemia Drugs Revenue by Application (2025-2030) & (US$ Million)

Table 43. Global Argininemia Drugs Revenue Share by Application (2019-2024)

Table 44. Global Argininemia Drugs Revenue Share by Application (2025-2030)

Table 45. Argininemia Drugs Price by Application (2019-2024) & (USD/Unit)

Table 46. Global Argininemia Drugs Price Forecast by Application (2025-2030) & (USD/Unit)

Table 47. US & Canada Argininemia Drugs Sales by Type (2019-2024) & (K Unit)

Table 48. US & Canada Argininemia Drugs Sales by Type (2025-2030) & (K Unit)

Table 49. US & Canada Argininemia Drugs Revenue by Type (2019-2024) & (US$ Million)

Table 50. US & Canada Argininemia Drugs Revenue by Type (2025-2030) & (US$ Million)

Table 51. US & Canada Argininemia Drugs Sales by Application (2019-2024) & (K Unit)

Table 52. US & Canada Argininemia Drugs Sales by Application (2025-2030) & (K Unit)

Table 53. US & Canada Argininemia Drugs Revenue by Application (2019-2024) & (US$ Million)

Table 54. US & Canada Argininemia Drugs Revenue by Application (2025-2030) & (US$ Million)

Table 55. US & Canada Argininemia Drugs Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 56. US & Canada Argininemia Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 57. US & Canada Argininemia Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 58. US & Canada Argininemia Drugs Sales by Country (2019-2024) & (K Unit)

Table 59. US & Canada Argininemia Drugs Sales by Country (2025-2030) & (K Unit)

Table 60. Europe Argininemia Drugs Sales by Type (2019-2024) & (K Unit)

Table 61. Europe Argininemia Drugs Sales by Type (2025-2030) & (K Unit)

Table 62. Europe Argininemia Drugs Revenue by Type (2019-2024) & (US$ Million)

Table 63. Europe Argininemia Drugs Revenue by Type (2025-2030) & (US$ Million)

Table 64. Europe Argininemia Drugs Sales by Application (2019-2024) & (K Unit)

Table 65. Europe Argininemia Drugs Sales by Application (2025-2030) & (K Unit)

Table 66. Europe Argininemia Drugs Revenue by Application (2019-2024) & (US$ Million)

Table 67. Europe Argininemia Drugs Revenue by Application (2025-2030) & (US$ Million)

Table 68. Europe Argininemia Drugs Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 69. Europe Argininemia Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 70. Europe Argininemia Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 71. Europe Argininemia Drugs Sales by Country (2019-2024) & (K Unit)

Table 72. Europe Argininemia Drugs Sales by Country (2025-2030) & (K Unit)

Table 73. China Argininemia Drugs Sales by Type (2019-2024) & (K Unit)

Table 74. China Argininemia Drugs Sales by Type (2025-2030) & (K Unit)

Table 75. China Argininemia Drugs Revenue by Type (2019-2024) & (US$ Million)

Table 76. China Argininemia Drugs Revenue by Type (2025-2030) & (US$ Million)

Table 77. China Argininemia Drugs Sales by Application (2019-2024) & (K Unit)

Table 78. China Argininemia Drugs Sales by Application (2025-2030) & (K Unit)

Table 79. China Argininemia Drugs Revenue by Application (2019-2024) & (US$ Million)

Table 80. China Argininemia Drugs Revenue by Application (2025-2030) & (US$ Million)

Table 81. Asia Argininemia Drugs Sales by Type (2019-2024) & (K Unit)

Table 82. Asia Argininemia Drugs Sales by Type (2025-2030) & (K Unit)

Table 83. Asia Argininemia Drugs Revenue by Type (2019-2024) & (US$ Million)

Table 84. Asia Argininemia Drugs Revenue by Type (2025-2030) & (US$ Million)

Table 85. Asia Argininemia Drugs Sales by Application (2019-2024) & (K Unit)

Table 86. Asia Argininemia Drugs Sales by Application (2025-2030) & (K Unit)

Table 87. Asia Argininemia Drugs Revenue by Application (2019-2024) & (US$ Million)

Table 88. Asia Argininemia Drugs Revenue by Application (2025-2030) & (US$ Million)

Table 89. Asia Argininemia Drugs Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 90. Asia Argininemia Drugs Revenue by Region (2019-2024) & (US$ Million)

Table 91. Asia Argininemia Drugs Revenue by Region (2025-2030) & (US$ Million)

Table 92. Asia Argininemia Drugs Sales by Region (2019-2024) & (K Unit)

Table 93. Asia Argininemia Drugs Sales by Region (2025-2030) & (K Unit)

Table 94. Middle East, Africa and Latin America Argininemia Drugs Sales by Type (2019-2024) & (K Unit)

Table 95. Middle East, Africa and Latin America Argininemia Drugs Sales by Type (2025-2030) & (K Unit)

Table 96. Middle East, Africa and Latin America Argininemia Drugs Revenue by Type (2019-2024) & (US$ Million)

Table 97. Middle East, Africa and Latin America Argininemia Drugs Revenue by Type (2025-2030) & (US$ Million)

Table 98. Middle East, Africa and Latin America Argininemia Drugs Sales by Application (2019-2024) & (K Unit)

Table 99. Middle East, Africa and Latin America Argininemia Drugs Sales by Application (2025-2030) & (K Unit)

Table 100. Middle East, Africa and Latin America Argininemia Drugs Revenue by Application (2019-2024) & (US$ Million)

Table 101. Middle East, Africa and Latin America Argininemia Drugs Revenue by Application (2025-2030) & (US$ Million)

Table 102. Middle East, Africa and Latin America Argininemia Drugs Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 103. Middle East, Africa and Latin America Argininemia Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 104. Middle East, Africa and Latin America Argininemia Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 105. Middle East, Africa and Latin America Argininemia Drugs Sales by Country (2019-2024) & (K Unit)

Table 106. Middle East, Africa and Latin America Argininemia Drugs Sales by Country (2025-2030) & (K Unit)

Table 107. Helsinn Healthcare Company Information

Table 108. Helsinn Healthcare Description and Major Businesses

Table 109. Helsinn Healthcare Argininemia Drugs Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 110. Helsinn Healthcare Argininemia Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 111. Helsinn Healthcare Recent Developments

Table 112. Novartis Pharmaceuticals Company Information

Table 113. Novartis Pharmaceuticals Description and Major Businesses

Table 114. Novartis Pharmaceuticals Argininemia Drugs Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 115. Novartis Pharmaceuticals Argininemia Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 116. Novartis Pharmaceuticals Recent Developments

Table 117. Horizon Pharma Company Information

Table 118. Horizon Pharma Description and Major Businesses

Table 119. Horizon Pharma Argininemia Drugs Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 120. Horizon Pharma Argininemia Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 121. Horizon Pharma Recent Developments

Table 122. Medicis Pharmaceutical Company Information

Table 123. Medicis Pharmaceutical Description and Major Businesses

Table 124. Medicis Pharmaceutical Argininemia Drugs Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 125. Medicis Pharmaceutical Argininemia Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 126. Medicis Pharmaceutical Recent Developments

Table 127. Key Raw Materials Lists

Table 128. Raw Materials Key Suppliers Lists

Table 129. Argininemia Drugs Distributors List

Table 130. Argininemia Drugs Customers List

Table 131. Argininemia Drugs Market Trends

Table 132. Argininemia Drugs Market Drivers

Table 133. Argininemia Drugs Market Challenges

Table 134. Argininemia Drugs Market Restraints

Table 135. Research Programs/Design for This Report

Table 136. Key Data Information from Secondary Sources

Table 137. Key Data Information from Primary Sources

List of Figures

Figure 1. Argininemia Drugs Product Picture

Figure 2. Global Argininemia Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Argininemia Drugs Market Share by Type in 2023 & 2030

Figure 4. Oral Product Picture

Figure 5. Injection Product Picture

Figure 6. Global Argininemia Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 7. Global Argininemia Drugs Market Share by Application in 2023 & 2030

Figure 8. Hospital

Figure 9. Drugs Stores

Figure 10. Other

Figure 11. Argininemia Drugs Report Years Considered

Figure 12. Global Argininemia Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Argininemia Drugs Revenue 2019-2030 (US$ Million)

Figure 14. Global Argininemia Drugs Revenue Market Share by Region in Percentage: 2023 Versus 2030

Figure 15. Global Argininemia Drugs Revenue Market Share by Region (2019-2030)

Figure 16. Global Argininemia Drugs Sales 2019-2030 ((K Unit)

Figure 17. Global Argininemia Drugs Sales Market Share by Region (2019-2030)

Figure 18. US & Canada Argininemia Drugs Sales YoY (2019-2030) & (K Unit)

Figure 19. US & Canada Argininemia Drugs Revenue YoY (2019-2030) & (US$ Million)

Figure 20. Europe Argininemia Drugs Sales YoY (2019-2030) & (K Unit)

Figure 21. Europe Argininemia Drugs Revenue YoY (2019-2030) & (US$ Million)

Figure 22. China Argininemia Drugs Sales YoY (2019-2030) & (K Unit)

Figure 23. China Argininemia Drugs Revenue YoY (2019-2030) & (US$ Million)

Figure 24. Asia (excluding China) Argininemia Drugs Sales YoY (2019-2030) & (K Unit)

Figure 25. Asia (excluding China) Argininemia Drugs Revenue YoY (2019-2030) & (US$ Million)

Figure 26. Middle East, Africa and Latin America Argininemia Drugs Sales YoY (2019-2030) & (K Unit)

Figure 27. Middle East, Africa and Latin America Argininemia Drugs Revenue YoY (2019-2030) & (US$ Million)

Figure 28. The Argininemia Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023

Figure 29. The Top 5 and 10 Largest Manufacturers of Argininemia Drugs in the World: Market Share by Argininemia Drugs Revenue in 2023

Figure 30. Global Argininemia Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 31. Global Argininemia Drugs Sales Market Share by Type (2019-2030)

Figure 32. Global Argininemia Drugs Revenue Market Share by Type (2019-2030)

Figure 33. Global Argininemia Drugs Sales Market Share by Application (2019-2030)

Figure 34. Global Argininemia Drugs Revenue Market Share by Application (2019-2030)

Figure 35. US & Canada Argininemia Drugs Sales Market Share by Type (2019-2030)

Figure 36. US & Canada Argininemia Drugs Revenue Market Share by Type (2019-2030)

Figure 37. US & Canada Argininemia Drugs Sales Market Share by Application (2019-2030)

Figure 38. US & Canada Argininemia Drugs Revenue Market Share by Application (2019-2030)

Figure 39. US & Canada Argininemia Drugs Revenue Share by Country (2019-2030)

Figure 40. US & Canada Argininemia Drugs Sales Share by Country (2019-2030)

Figure 41. U.S. Argininemia Drugs Revenue (2019-2030) & (US$ Million)

Figure 42. Canada Argininemia Drugs Revenue (2019-2030) & (US$ Million)

Figure 43. Europe Argininemia Drugs Sales Market Share by Type (2019-2030)

Figure 44. Europe Argininemia Drugs Revenue Market Share by Type (2019-2030)

Figure 45. Europe Argininemia Drugs Sales Market Share by Application (2019-2030)

Figure 46. Europe Argininemia Drugs Revenue Market Share by Application (2019-2030)

Figure 47. Europe Argininemia Drugs Revenue Share by Country (2019-2030)

Figure 48. Europe Argininemia Drugs Sales Share by Country (2019-2030)

Figure 49. Germany Argininemia Drugs Revenue (2019-2030) & (US$ Million)

Figure 50. France Argininemia Drugs Revenue (2019-2030) & (US$ Million)

Figure 51. U.K. Argininemia Drugs Revenue (2019-2030) & (US$ Million)

Figure 52. Italy Argininemia Drugs Revenue (2019-2030) & (US$ Million)

Figure 53. Russia Argininemia Drugs Revenue (2019-2030) & (US$ Million)

Figure 54. China Argininemia Drugs Sales Market Share by Type (2019-2030)

Figure 55. China Argininemia Drugs Revenue Market Share by Type (2019-2030)

Figure 56. China Argininemia Drugs Sales Market Share by Application (2019-2030)

Figure 57. China Argininemia Drugs Revenue Market Share by Application (2019-2030)

Figure 58. Asia Argininemia Drugs Sales Market Share by Type (2019-2030)

Figure 59. Asia Argininemia Drugs Revenue Market Share by Type (2019-2030)

Figure 60. Asia Argininemia Drugs Sales Market Share by Application (2019-2030)

Figure 61. Asia Argininemia Drugs Revenue Market Share by Application (2019-2030)

Figure 62. Asia Argininemia Drugs Revenue Share by Region (2019-2030)

Figure 63. Asia Argininemia Drugs Sales Share by Region (2019-2030)

Figure 64. Japan Argininemia Drugs Revenue (2019-2030) & (US$ Million)

Figure 65. South Korea Argininemia Drugs Revenue (2019-2030) & (US$ Million)

Figure 66. China Taiwan Argininemia Drugs Revenue (2019-2030) & (US$ Million)

Figure 67. Southeast Asia Argininemia Drugs Revenue (2019-2030) & (US$ Million)

Figure 68. India Argininemia Drugs Revenue (2019-2030) & (US$ Million)

Figure 69. Middle East, Africa and Latin America Argininemia Drugs Sales Market Share by Type (2019-2030)

Figure 70. Middle East, Africa and Latin America Argininemia Drugs Revenue Market Share by Type (2019-2030)

Figure 71. Middle East, Africa and Latin America Argininemia Drugs Sales Market Share by Application (2019-2030)

Figure 72. Middle East, Africa and Latin America Argininemia Drugs Revenue Market Share by Application (2019-2030)

Figure 73. Middle East, Africa and Latin America Argininemia Drugs Revenue Share by Country (2019-2030)

Figure 74. Middle East, Africa and Latin America Argininemia Drugs Sales Share by Country (2019-2030)

Figure 75. Brazil Argininemia Drugs Revenue (2019-2030) & (US$ Million)

Figure 76. Mexico Argininemia Drugs Revenue (2019-2030) & (US$ Million)

Figure 77. Turkey Argininemia Drugs Revenue (2019-2030) & (US$ Million)

Figure 78. Israel Argininemia Drugs Revenue (2019-2030) & (US$ Million)

Figure 79. GCC Countries Argininemia Drugs Revenue (2019-2030) & (US$ Million)

Figure 80. Argininemia Drugs Value Chain

Figure 81. Argininemia Drugs Production Process

Figure 82. Channels of Distribution

Figure 83. Distributors Profiles

Figure 84. Bottom-up and Top-down Approaches for This Report

Figure 85. Data Triangulation

Figure 86. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Brigatinib Tablet Market Insights, Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-13E9982

Fri Dec 27 00:00:00 UTC 2024

Add to Cart

Global Durezol Market Insights, Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-22W864

Fri Dec 27 00:00:00 UTC 2024

Add to Cart

Global Rats Model Services Market Insights, Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-39V834

Fri Dec 27 00:00:00 UTC 2024

Add to Cart

Global Argininemia Drugs Market Insights, Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-11E9950

Fri Dec 27 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions